Study S003294

A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE DOSE, PARALLEL GROUP STUDY TO ASSESS RELATIVE BIOAVAILABILITY OF PF-08653944 WHEN ADMINISTERED ACROSS DIFFERENT INJECTION SITES IN ADULTS WITH OVERWEIGHT OR OBESITY

ClinicalTrials.gov record

Registration

Registration: NCT07400679
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: COMPLETED
Enrollment: 48
Start: 2026-02-04
Primary completion: 2026-07-02
Lead sponsor: Pfizer
Conditions: Overweight; Obesity; Healthy
Interventions: DRUG:PF-08653944
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

Pharmacokinetics (PK): Area Under the Concentration Versus Time Curve (AUC) of PF-08653944 [Up to 85 days]
PK: Maximum Observed Concentration (Cmax) of PF-08653944 [Up to 85 days]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.